Health & Life Co., Ltd. (TPEX:1781)
7.60
-0.50 (-6.17%)
Nov 20, 2026, 1:18 PM CST
Health & Life Revenue
Health & Life had revenue of 77.74M TWD in the quarter ending September 30, 2026, a decrease of -13.19%. This brings the company's total for the last twelve months to 388.28M, down -12.12% year-over-year. In the year 2025, Health & Life had annual revenue of 398.05M, down -43.65%. That makes Health & Life the 36,681st largest company in the world by revenue and 1,917th in Taiwan.
Revenue (ttm)
388.28M
Revenue Growth
-12.12%
P/S Ratio
0.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
360.30M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Health & Life breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 398.05M | -308.34M | -43.65% |
| Dec 31, 2024 | 706.39M | 105.22M | 17.50% |
| Dec 31, 2023 | 601.17M | -196.37M | -24.62% |
| Dec 31, 2022 | 797.54M | -14.34M | -1.77% |
| Dec 31, 2021 | 811.88M | 37.72M | 4.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 2.95B |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 417.97M |
| EPS Bio Technology | 380.33M |
| Taiwan Advanced Nanotech | 170.57M |
| PlexBio | 137.57M |
| iXensor | 26.67M |